An innovative therapeutic strategy to treat colon cancer is discovered

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

It has been identified how the combination of inhibitors of PP2A and WEE1 proteins induces the death of colon cancer cells, offering a new perspective in the treatment of this disease.

Read more

The amino acid L-serine shows efficacy in treating patients with mutations in GRIN genes

by Fundació Clínic per a la Recerca Biomèdica

A clinical trial has demonstrated the potential of the amino acid L-serine, administered as an oral supplement, to improve the function of glutamate receptors in patients with GRINpathies.

Read more

Palobiofarma announces the completion the Phase II clinical trial with its investigational therapy PBF-680 in chronic obstructive pulmonary disease (COPD) patients

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visit” of the Phase II trial investigating the safety and preliminary efficacy of PBF-680 in moderate to severe COPD patients.

Read more

Laminar Pharma opens a new seek capital round of up to seven million euros

by Laminar Pharma

Laminar Pharma opens a new financing round of up to seven million euros. The objective is to finish financing the development of its drug LAM561 against the most aggressive and common brain cancer, gl...

Read more

Nueva línea de investigación para el tratamiento de ELA

by Universitat Politècnica de València

Un estudio propone un novedoso enfoque para frenar la degeneración neuromuscular en pacientes con Esclerosis Lateral Amiotrófica

Read more

INCLIVA evalúa la seguridad y tolerabilidad de blinatumomab administrado de forma subcutánea en el tratamiento de leucemia linfoblástica aguda en adultos

by INCLIVA

El Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico Universitario de València, ha impulsado un ensayo clínico para evaluar la seguridad y la tolerabilidad del anticuerpo blinatum...

Read more

Un estudio preclínico mejora el tratamiento de los tumores cerebrales pediátricos más agresivos

by CIMA - Centro de Investigación Médica Aplicada

Investigadores del Cima Universidad de Navarra constatan que la combinación de dos fármacos, ya conocidos, abre el camino a posibles ensayos clínicos para combatir los gliomas difusos de línea med...

Read more

The Future of Pharmaceutical Innovation

by Laboratorios Rubió, S.A.

This article explores the current state of pharmaceutical innovation, predicts future trends, and discusses the role of artificial intelligence in shaping the industry. Furthermore, it highlights the ...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

CRB Health Tech realiza el primer cierre...

by CRB Inverbío SA SGECR

Con la incorporación de Sanitas y las suscripciones ya firmadas con a...

Photos Stream